H Irene Su1,2, Shaylyn Stark3, Brian Kwan3,4, Sarah Boles3,5, Diana Chingos6, Jennifer Ehren7, Jessica R Gorman8, Michael Krychman9, Sally A D Romero10, Jun J Mao10, John P Pierce3,4, Loki Natarajan3,4. 1. Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Diego, San Diego, USA. hisu@ucsd.edu. 2. Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive, Dept. 0901, La Jolla, San Diego, CA, 92093-0901, USA. hisu@ucsd.edu. 3. Moores Cancer Center, University of California San Diego, 3855 Health Sciences Drive, Dept. 0901, La Jolla, San Diego, CA, 92093-0901, USA. 4. Department of Family and Preventive Medicine, University of California San Diego, San Diego, USA. 5. Department of Medicine, University of California San Diego, San Diego, USA. 6. Young Survival Coalition, New York, USA. 7. Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, USA. 8. School of Social and Behavioral Health Sciences, Oregon State University College of Public Health and Human Sciences, Corvalis, USA. 9. Southern California Center for Sexual Health and Survivorship Medicine, Newport Beach, USA. 10. Bendheim Integrative Medicine Center, Memorial Sloan Kettering Cancer Center, New York, USA.
Abstract
PURPOSE:Breast cancer survivorship care plans (SCP) have limited content addressing women's health issues. This trial tested if young breast cancer survivors who receive a web-based, women's health SCP were more likely to improve on at least one of the four targeted issues (hot flashes, fertility-related concerns, contraception, and vaginal symptoms) compared to attention controls. METHODS: A randomized controlled trial recruited female survivors ages 18-45 at diagnosis, 18-50 at enrollment, completed primary cancer treatment, and had a significant women's health issue: moderate or higher fertility-related concerns; ≥ 4 hot flashes/day with ≥ 1 of moderate severity; ≥ 1 moderate vaginal atrophy symptoms; or not contracepting/using less effective methods. Survivors underwent stratified, block randomization with equal allocation to intervention and control groups. The intervention group accessed the online SCP; controls accessed curated resource lists. In intention-to-treat analysis, the primary outcome of improvement in at least one issue by 24 weeks was compared by group. RESULTS:182 participants (86 intervention, 96 control), mean age 40.0 ± 5.9 and 4.4 ± 3.2 years since diagnosis, were randomized. 61 intervention group participants (70.9%) improved, compared to 55 controls (57.3%) (OR 1.82, 95% CI 0.99-3.4, p = 0.057). The following issue-specific improvements were observed in the intervention versus control arms: fertility-related concerns (27.9% vs. 14.6%, OR 2.3, 95% CI 1.1-4.8); hot flashes (58.5% vs. 55.8%, OR 1.1, 95% CI 0.57-2.2); vaginal symptoms (42.5% vs. 40.7%, OR 1.1, 95% CI 0.6-2.0); contraception (50% vs. 42.6%, OR 1.4, 95% CI 0.74-2.5). CONCLUSIONS: In young breast cancer survivors, a novel, web-based SCP did not result in more change in the primary outcome of improvement in at least one of the four targeted women's health issues, than the attention control condition. The intervention was associated with improved infertility concerns, supporting efficacy of disseminating accessible, evidence-based women's health information to this population.
RCT Entities:
PURPOSE:Breast cancer survivorship care plans (SCP) have limited content addressing women's health issues. This trial tested if young breast cancer survivors who receive a web-based, women's health SCP were more likely to improve on at least one of the four targeted issues (hot flashes, fertility-related concerns, contraception, and vaginal symptoms) compared to attention controls. METHODS: A randomized controlled trial recruited female survivors ages 18-45 at diagnosis, 18-50 at enrollment, completed primary cancer treatment, and had a significant women's health issue: moderate or higher fertility-related concerns; ≥ 4 hot flashes/day with ≥ 1 of moderate severity; ≥ 1 moderate vaginal atrophy symptoms; or not contracepting/using less effective methods. Survivors underwent stratified, block randomization with equal allocation to intervention and control groups. The intervention group accessed the online SCP; controls accessed curated resource lists. In intention-to-treat analysis, the primary outcome of improvement in at least one issue by 24 weeks was compared by group. RESULTS: 182 participants (86 intervention, 96 control), mean age 40.0 ± 5.9 and 4.4 ± 3.2 years since diagnosis, were randomized. 61 intervention group participants (70.9%) improved, compared to 55 controls (57.3%) (OR 1.82, 95% CI 0.99-3.4, p = 0.057). The following issue-specific improvements were observed in the intervention versus control arms: fertility-related concerns (27.9% vs. 14.6%, OR 2.3, 95% CI 1.1-4.8); hot flashes (58.5% vs. 55.8%, OR 1.1, 95% CI 0.57-2.2); vaginal symptoms (42.5% vs. 40.7%, OR 1.1, 95% CI 0.6-2.0); contraception (50% vs. 42.6%, OR 1.4, 95% CI 0.74-2.5). CONCLUSIONS: In young breast cancer survivors, a novel, web-based SCP did not result in more change in the primary outcome of improvement in at least one of the four targeted women's health issues, than the attention control condition. The intervention was associated with improved infertility concerns, supporting efficacy of disseminating accessible, evidence-based women's health information to this population.
Entities:
Keywords:
Breast cancer; Fertility; Randomized controlled trial; Reproductive health; Survivorship care plan
Authors: Joseph M Letourneau; Erin E Ebbel; Patricia P Katz; Audra Katz; Wei Z Ai; A Jo Chien; Michelle E Melisko; Marcelle I Cedars; Mitchell P Rosen Journal: Cancer Date: 2011-09-01 Impact factor: 6.860
Authors: Ellen B Gold; Shirley W Flatt; John P Pierce; Wayne A Bardwell; Richard A Hajek; Vicky A Newman; Cheryl L Rock; Marcia L Stefanick Journal: Menopause Date: 2006 May-Jun Impact factor: 2.953
Authors: Jessica R Gorman; Vanessa L Malcarne; Scott C Roesch; Lisa Madlensky; John P Pierce Journal: Breast Cancer Res Treat Date: 2010-02-04 Impact factor: 4.872
Authors: H Irene Su; Mary D Sammel; Jamie Green; Luke Velders; Corrie Stankiewicz; Jennifer Matro; Ellen W Freeman; Clarisa R Gracia; Angela DeMichele Journal: Cancer Date: 2010-02-01 Impact factor: 6.860
Authors: Allison Marziliano; Michael A Diefenbach; Shawna V Hudson; Erin K Tagai; Elizabeth A Handorf; Alicja Bator; Suzanne M Miller Journal: J Med Internet Res Date: 2022-03-21 Impact factor: 7.076
Authors: Anna Dornisch; Emily H Yang; Jamie Gruspe; Erin R Roesch; Paula Aristizabal; Greg A Aarons; Teresa Helsten; Michelle B Takemoto; Sally A D Romero; Bonnie N Kaiser; Hui-Chun Irene Su Journal: J Adolesc Young Adult Oncol Date: 2021-01-19 Impact factor: 1.757